Mark Fraser
Impact in
- Microbiology top 5%
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 17
- Epidemiology 14
- Fungal Infections and Studies 12
- Nail Diseases and Treatments 3
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- Andrew M. Borman (22 shared papers)Elizabeth M. Johnson (19 shared papers)M. Dean Palmer (8 shared papers)Colin Campbell (1 shared paper)Zoe Patterson (7 shared papers)Adrien Székely (6 shared papers)Zoe Ann Brown (1 shared paper)Christopher J. Linton (5 shared papers)
- Journals
- Medical Mycology (8 papers)Journal of Fungi (3 papers)Journal of Clinical Microbiology (3 papers)Mycopathologia (2 papers)Journal of Clinical Pathology (1 paper)
- Partner nations
- United KingdomNetherlandsSaudi Arabia
In The Last Decade
Mark Fraser
24 papers receiving 731 citations
Peers
Comparison fields: 5 of 72
- Microbiology 20
- Infectious Diseases 428
- Cell Biology 275
- Epidemiology 473
- Applied Microbiology and Biotechnology 22
Countries citing papers authored by Mark Fraser
This map shows the geographic impact of Mark Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fraser more than expected).
Fields of papers citing papers by Mark Fraser
This network shows the impact of papers produced by Mark Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fraser. The network helps show where Mark Fraser may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Fraser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 139 | |
| 2 | 2015 | 68 | |
| 3 | 2020 | 68 | |
| 4 | 2020 | 65 | |
| 5 | 2019 | 53 | |
| 6 | 2017 | 51 | |
| 7 | 2017 | 39 | |
| 8 | 2019 | 34 | |
| 9 | 2020 | 32 | |
| 10 | 2021 | 30 | |
| 11 | 2010 | 27 | |
| 12 | 2023 | 25 | |
| 13 | 2017 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 2018 | 16 | |
| 16 | 2022 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2012 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2022 | 5 |
About Mark Fraser
Mark Fraser is a scholar working on Infectious Diseases, Epidemiology, Cell Biology, Plant Science and Clinical Biochemistry, having authored 25 papers that have together received 756 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (17 papers), Fungal Infections and Studies (12 papers), Plant Pathogens and Fungal Diseases (11 papers), Bacterial Identification and Susceptibility Testing (4 papers), Nail Diseases and Treatments (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Enterobacteriaceae and Cronobacter Research (2 papers) and Mycorrhizal Fungi and Plant Interactions (2 papers). The work is most often cited by research in Microbiology (20 citations), Infectious Diseases (428 citations), Cell Biology (275 citations), Epidemiology (473 citations) and Applied Microbiology and Biotechnology (22 citations). Mark Fraser has collaborated with scholars based in United Kingdom, Netherlands and Saudi Arabia. Frequent co-authors include Andrew M. Borman, Elizabeth M. Johnson, M. Dean Palmer, Colin Campbell, Zoe Patterson, Adrien Székely, Zoe Ann Brown, Christopher J. Linton, Julian Müller and Daniel E. Larcombe. Their work appears in journals such as Medical Mycology, Journal of Fungi, Journal of Clinical Microbiology, Mycopathologia and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.